–
CytomX Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−116
FY22:
−101
FY23:
−6.48
FY24:
25.0
FY25:
−22.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−113
FY22:
−98.9
FY23:
−4.31
FY24:
26.8
FY25:
−21.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−116
FY22:
−99.3
FY23:
3.32
FY24:
32.1
FY25:
−17.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−116
FY22:
−99.3
FY23:
−0.57
FY24:
31.9
FY25:
−17.4
All amounts in millions USD